Understand the bias, discover the truth in your news. Get Started
The Daily Signal Article Rating

Trump to Sign Executive Order to Slash Prescription Drug Prices

  • Bias Rating

    42% Medium Right

  • Reliability

    65% ReliableAverage

  • Policy Leaning

    62% Medium Right

  • Politician Portrayal

    -3% Negative

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

-4% Negative

  •   Liberal
  •   Conservative
SentenceSentimentBias
Unlock this feature by upgrading to the Pro plan.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

56% : "I am pleased to announce that Tomorrow morning, in the White House, at 9:00 A.M., I will be signing one of the most consequential Executive Orders in our Country's history," Trump said in a Sunday evening announcement on X. "Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.
42% : Trump claimed he is able to take this action while others won't because he is immune to the political effect of pharmaceutical company campaign donations.
41% : "Government price setting in any form is bad for American patients," said Alex Schriver, a spokesperson for the Pharmaceutical Research and Manufacturers of America -- known as PhRMA -- in a statement to Reuters when asked about Trump's planned executive order.
33% : Drugmakers believe actions such as the one Trump will take Monday reduce incentives to develop new drugs and are harmful in the long run.
26% : In his statement, Trump rejected what he contended was the argument from drug companies that research and development costs had to be borne by U.S. consumers, saying the manufacturers were making "suckers" of Americans.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Copy link